Published in Cancer Weekly, August 28th, 2007
"The objective of the study was to determine whether anti-PEG was associated with rapid clearance PEG-ASNase. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.